Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose N-acetylcysteine versus placebo for prevention of exacerbations in moderate to severe COPD
ChiCTR-TRC-09000460Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: Yearly acute exacerbation rate. Started Feb 2009; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000460.